Skip to content

Donate in Honor of Someone​ You Love

Honor a Loved One

Every day, patients and families around the world are impacted by ovarian cancer. And every day, OCRA-funded scientists are working on the most promising research to create new, more effective treatments, achieve desperately needed breakthroughs, and get closer to a cure. Honor or remember a loved one by giving a dedicated donation.

Related Topics

FDA Approves Lifyorli Plus Abraxane for Platinum-Resistant Ovarian Cancer

FDA Approves Lifyorli Plus Abraxane for Platinum-Resistant Ovarian Cancer

On March 25, 2026, the U.S. Food and Drug Administration (FDA) approved Lifyorli (relacorilant), made by Corcept Therapeutics, in combination with Abraxane (nab-paclitaxel) for adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have received one to three prior lines of treatment, including prior Avastin (bevacizumab).  The approval follows last month’s FDA … Continued

Read more

The Overview: March 2026

The Overview: March 2026

OCRA’s Annual Advocacy Day Draws Survivors and Caregivers from Across the Country More than 120 gynecologic cancer survivors, caregivers, researchers and supporters from nearly forty states filled the halls of the U.S. Capitol on Tuesday, March 17—dressed in teal, the color of ovarian cancer awareness—as Ovarian Cancer Research Alliance (OCRA) held its annual Spring Advocacy Day. The … Continued

Read more

April Programs: New Offerings, Fresh Topics, and More

April Programs: New Offerings, Fresh Topics, and More

April is a full month at OCRA, with several new programs joining our ongoing lineup of workshops, educational sessions, and community events. Whether you’re looking for practical guidance, clinical information, or simply a chance to connect and create, there’s something here for you. New and Expanded Programs Advanced Care Planning Workshop Series April 6, 13, … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.